Oasmia Pharmaceutical AB
UPPSALA, Sweden, July 15, 2010 - ABOUT OASMIA
Oasmia is developing a new generation of drugs with emphasis
on human and veterinary oncology.
UPPSALA, Sweden - Oasmia Pharmaceutical, Uppsala, Sweden, has been granted Orphan Drug designation by the USA FDA of Paclical(R) for the treatment of ovarian cancer.
